<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Posterior reversible <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> syndrome (PRES) is a clinicoradiologic entity characterized by <z:hpo ids='HP_0002315'>headaches</z:hpo>, <z:e sem="disease" ids="C0278061" disease_type="Mental or Behavioral Dysfunction" abbrv="">altered mental status</z:e>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, <z:hpo ids='HP_0000572'>visual loss</z:hpo>, and characteristic imaging pattern in brain MRI </plain></SENT>
<SENT sid="1" pm="."><plain>The cause of PRES is not yet understood </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (<z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>/5-Fluoracil/Leucovorin) chemotherapy for a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>